A 53-year-old man had a 17-year history of well-controlled HIV/AIDS. He reported the development of droopy eyelids over the past several years. The patient underwent an uncomplicated levator advancement procedure 5 years prior. His condition remained undercorrected. His HIV medications included enteric-coated didanosine (Videx EC; Bristol-Myers Squibb Co), tenofovir disoproxil fumarate (Viread; Gilead Sciences, Inc, Foster City, California), and abacavir sulfate (Ziagen; GlaxoSmithKline), all of which are nucleoside analogues similar to zidovudine, as well as nevirapine (Viramune; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut), which is a nonnucleoside reverse transcriptase inhibitor. The patient demonstrated a CD4 lymphocyte count of 343/μL.